(Q39652499)

13 September 2017

title

Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database (English)

1 reference

13 September 2017

0 references

Maryse Lapeyre-Mestre

object named as

M Lapeyre-Mestre

5

0 references

author name string

G Moulis

1

1 reference

13 September 2017

J Béné

2

1 reference

13 September 2017

A Sommet

3

1 reference

13 September 2017

L Sailler

4

1 reference

13 September 2017

J-L Montastruc

6

1 reference

13 September 2017

French Association of PharmacoVigilance Centres

7

1 reference

13 September 2017

publication date

14 February 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

21

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

885-889

1 reference

Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Lupus-like syndrome associated with statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

The medical dictionary for regulatory activities (MedDRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312436861

21 January 2018

Identifiers

DOI

10.1177/0961203312436861

1 reference

13 September 2017

1 reference